Neonatal outcomes in women with diabetes mellitus — analysis of DAPSY data

Abstract

BACKGROUND: Hyperglycemia in pregnancy is associated with short- and long-term implications for children. Nevertheless, the effects of different types of diabetes mellitus and treatment methods on the neonatal outcomes are to be investigated.

AIM: The aim of this study was to evaluate the contribution of different types of maternal diabetes mellitus to the risk of adverse neonatal outcomes.

MATERIALS AND METHODS: This retrospective cohort study included women (n = 3261) who delivered at the Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott, Saint Petersburg, Russia in 2008–2017. The following comparison groups were used: type 1 diabetes mellitus (n = 506; 1a, continuous subcutaneous insulin injections; 1b, multiple daily insulin injections), type 2 diabetes mellitus (n = 229; 2a, diet; 2b, insulin therapy), gestational diabetes mellitus (n = 2387; 3a, diet; 3b, insulin therapy), and control (n = 139). The main birth outcomes assessed included weight and length of newborns, Apgar score at birth and at 5 minutes after birth, and pathological conditions such as fetal macrosomia, syndrome of infant of mother with gestational diabetes mellitus or diabetic mother (P70.0–P70.1), light (P05.0) or small for gestational age (P05.1), intrauterine growth restriction, prematurity (P07), neonatal hypoglycemia (P70.4), and neonatal respiratory distress syndrome (P22). The secondary birth outcomes assessed included birth trauma (P10–P15), stillbirth (P95), disturbances of cerebral status of newborn (P91), and congenital malformations, deformations and chromosomal abnormalities (Q00–Q99).

RESULTS: Pregestational diabetes mellitus is strongly associated with adverse neonatal outcomes. Type 1 diabetes mellitus women had the highest risks for fetal macrosomia and diabetic fetopathy, neonatal hypoglycemia, prematurity, and congenital malformations (odds ratio 3.54, 20.2, 5.59, 4.24 and 3.92 respectively). In type 2 diabetes mellitus patients, the risks of low birth weight, intrauterine growth restriction and birth trauma (odds 9.14, 5.42 and 6.3 respectively) were higher. For women with gestational diabetes mellitus, these risks were lower.

CONCLUSIONS: This study provides a comprehensive analysis of the major neonatal pathology in patients with different types of diabetes mellitus, taking into account the treatment method. Preconception care and optimal glycemic control are necessary to reduce the risk of obstetric and perinatal complications in women with pregestational types of diabetes mellitus. Further research into the health status of this cohort of children at a later age is required.

Keywords

diabetes mellitus / pregnancy complications / fetal macrosomia / fetal growth restriction / congenital malformations / deformations / chromosomal disorders

References

[1] Wang H, Li N, Chivese T, et al. IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group’s criteria. Diabetes Res Clin Pract. 2022;183. doi: 10.1016/j.diabres.2021.109050

[2] Wang H., Li N., Chivese T., et al. IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group’s criteria // Diabetes Res Clin Pract. 2022. Vol. 183. doi: 10.1016/j.diabres.2021.109050

[3] Rodolaki K, Pergialiotis V, Iakovidou N, et al. The impact of maternal diabetes on the future health and neurodevelopment of the offspring: a review of the evidence. Front Endocrinol (Lausanne). 2023;14. doi: 10.3389/fendo.2023.1125628

[4] Rodolaki K., Pergialiotis V., Iakovidou N., et al. The impact of maternal diabetes on the future health and neurodevelopment of the offspring: a review of the evidence // Front Endocrinol (Lausanne). 2023. Vol. 14. doi: 10.3389/fendo.2023.1125628

[5] Eletri L, Mitanchez D. How do the different types of maternal diabetes during pregnancy influence offspring outcomes? Nutrients. 2022;14(18):3870. doi: 10.3390/nu14183870

[6] Eletri L., Mitanchez D. How do the different types of maternal diabetes during pregnancy influence offspring outcomes? // Nutrients. 2022. Vol. 14, N 18. P. 3870. doi: 10.3390/nu14183870

[7] Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377. doi: 10.1136/bmj-2021-067946

[8] Ye W., Luo C., Huang J., et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis // BMJ. 2022. Vol. 377. doi: 10.1136/bmj-2021-067946

[9] Malaza N, Masete M, Adam S, et al. A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabetes. Int J Environ Res Public Health. 2022;19(17). doi: 10.3390/ijerph191710846

[10] Malaza N., Masete M., Adam S., et al. A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabetes // Int J Environ Res Public Health. 2022. Vol. 19, N. 17. doi: 10.3390/ijerph191710846

[11] Alekseenkova EN, Babakov VN, Selkov SA, et al. Maternal insulin-like growth factors and insulin-like growth factor-binding proteins for macrosomia prediction in diabetic and nondiabetic pregnancy: a prospective study. Int J Gynaecol Obstet. 2023;162(2):605–613. doi: 10.1002/ijgo.14696

[12] Alekseenkova E.N., Babakov V.N., Selkov S.A., et al. Maternal insulin-like growth factors and insulin-like growth factor-binding proteins for macrosomia prediction in diabetic and nondiabetic pregnancy: a prospective study // Int J Gynaecol Obstet. 2023. Vol. 162, N. 2. P. 605–613. doi: 10.1002/ijgo.14696

[13] Kapustin R, Kopteeva E, Tiselko A, et al. Diabetes and pregnancy study (DAPSY): a 10-year single-center cohort study of pregnancies affected by diabetes. Arch Gynecol Obstet. 2023. doi: 10.1007/s00404-023-07187-2

[14] Kapustin R., Kopteeva E., Tiselko A., et al. Diabetes and pregnancy study (DAPSY): a 10-year single-center cohort study of pregnancies affected by diabetes // Archives of Gynecology and Obstetrics. 2023. doi: 10.1007/s00404-023-07187-2

[15] Kapustin RV. Beremennost’ i sakharnyy diabet: patogenez, prognozirovaniye akusherskikh i perinatal’nykh oslozhneniy, taktika vedeniya gestatsionnogo perioda i rodorazresheniya [dissertation]. Saint Petersburg; 2022 [cited 12.01.2024]. Available from: https://www.dissercat.com/content/beremennost-i-sakharnyi-diabet-patogenez-prognozirovanie-akusherskikh-i-perinatalnykh-oslozh (In Russ.) EDN: MXSOKA

[16] Капустин Р.В. Беременность и сахарный диабет: патогенез, прогнозирование акушерских и перинатальных осложнений, тактика ведения гестационного периода и родоразрешения: дис. … доктора мед. наук. Санкт-Петербург, 2022. Режим доступа: https://www.dissercat.com/content/beremennost-i-sakharnyi-diabet-patogenez-prognozirovanie-akusherskikh-i-perinatalnykh-oslozh. Дата обращения: 12.01.2024. EDN: MXSOKA

[17] Dedov II, Shestakova MV, Mayorov AYu, editors. Standards of specialized diabetes care. 10th edn. Moscow; 2021 [cited 12.01.2024]. doi: 10.14341/DM12802. Available from: https://congress-med.ru/assets/files/2021/2021-rossijskie-algoritmyi-po-lecheniyu-saxarnogo-diabeta.pdf (In Russ.)

[18] Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Клинические рекомендации / под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. Москва, 2021. doi: 10.14341/DM12802. Режим доступа: https://congress-med.ru/assets/files/2021/2021-rossijskie-algoritmyi-po-lecheniyu-saxarnogo-diabeta.pdf. Дата обращения: 12.01.2024

[19] Tiselko AV, Kapustin RV, Milyutina YP, et al. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus. J Matern Fetal Neonatal Med. 2022;35(25):9639–9646. doi: 10.1080/14767058.2022.2050361

[20] Tiselko A.V., Kapustin R.V., Milyutina Y.P., et al. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus // J Matern Fetal Neonatal Med. 2022. Vol. 35, N. 25. P. 9639–9646. doi: 10.1080/14767058.2022.2050361

[21] Kharitonova LA, Papysheva OV, Bogomaz LV, et al. Physical development of newborns born to mothers with different carbohydrate metabolism disorders. Experimental and Clinical Gastroenterology. 2019;(1):88–98. EDN: FMYMLT doi: 10.31146/1682-8658-ecg-161-1-88-98

[22] Харитонова Л.А., Папышева О.В., Богомаз Л.В., и др. Физическое развитие новорожденных, родившихся от матерей с различными нарушениями углеводного обмена // Экспериментальная и клиническая гастроэнтерология. 2019. № 1(161). С. 88–98. EDN: FMYMLT doi: 10.31146/1682-8658-ecg-161-1-88-98

[23] Remneva OV, Rozhkova OV, Cherkasova TM, et al. Clinical, metabolic and neurological disorders in full-term newborns from mothers with gestational diabetes mellitus. Russian Bulletin of Perinatology and Pediatrics. 2021;66(3):46–51. EDN: DUKWJG doi: 10.21508/1027-4065-2021-66-3-46-51

[24] Ремнева О.В., Рожкова О.В., Черкасова Т.М., и др. Клинико-метаболические и неврологические нарушения у доношенных новорожденных от матерей с гестационным сахарным диабетом // Российский вестник перинатологии и педиатрии. 2021. Т. 66, № 3. С. 46–51. EDN: DUKWJG doi: 10.21508/1027-4065-2021-66-3-46-51

[25] Cordero L, Treuer SH, Landon MB, et al. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152(3):249–254. doi: 10.1001/archpedi.152.3.249

[26] Cordero L., Treuer S.H., Landon M.B., et al. Management of infants of diabetic mothers // Arch Pediatr Adolesc Med. 1998. Vol. 152, N. 3. P. 249–254. doi: 10.1001/archpedi.152.3.249

[27] Kapustin RV, Kopteyeva EV, Tral TG, et al. Placental morphology in different types of diabetes mellitus. Journal of Obstetrics and Women’s Diseases. 2021;70(2):13–26. EDN: FBLSJP doi: 10.17816/JOWD57149

[28] Капустин Р.В., Коптеева Е.В., Траль Т.Г., и др. Морфологическое строение плаценты при различных типах сахарного диабета // Журнал акушерства и женских болезней. 2021. Т. 70, № 2. C. 13–26. EDN: FBLSJP doi: 10.17816/JOWD57149

[29] Kopteyeva EV, Shelayeva EV, Alekseenkova EN, et al. Fetal growth restriction in diabetic pregnancy: a retrospective single-center study. Journal of Obstetrics and Women’s Diseases. 2022;71(6):15–27. EDN: DOVASE doi: 10.17816/JOWD115018

[30] Коптеева Е.В., Шелаева Е.В., Алексеенкова Е.Н., и др. Задержка роста плода у беременных с сахарным диабетом: анализ данных ретроспективного одноцентрового исследования // Журнал акушерства и женских болезней. 2022. Т. 71, № 6. C. 15–27. EDN: DOVASE doi: 10.17816/JOWD115018

[31] Begum S, Dey SK, Fatema K. Neonatal glycemic status of infants of diabetic mothers in a tertiary care hospital. Indian J Endocrinol Metab. 2018;22:621–626. doi: 10.4103/ijem.ijem_689_17

[32] Begum S., Dey S.K., Fatema K. Neonatal glycemic status of infants of diabetic mothers in a tertiary care hospital // Indian J Endocrinol Metab. 2018. Vol. 22. P. 621–626. doi: 10.4103/ijem.ijem_689_17

[33] Kapustin RV, Kopteeva EV, Alekseenkova EN, et al. Analysis of risk factors and perinatal mortality structure in pregnant patients with diabetes mellitus. Doktor.Ru. 2021;20(6):46–52. EDN: CFVOPZ doi: 10.31550/1727-2378-2021-20-6-46-52

[34] Капустин Р.В., Коптеева Е.В., Алексеенкова Е.Н., и др. Анализ факторов риска и структуры перинатальных потерь у беременных с сахарным диабетом // Доктор.Ру. 2021. Т. 20, № 6. С. 46–52. EDN: CFVOPZ doi: 10.31550/1727-2378-2021-20-6-46-52

[35] Kapustin RV, Alekseyenkova EN, Arzhanova ON, et al. Preterm birth in women with diabetes mellitus. Journal of Obstetrics and Women’s Diseases. 2020;69(1):17–26. EDN: IURNDK doi: 10.17816/JOWD69117-26

[36] Капустин Р.В., Алексеенкова Е.Н., Аржанова О.Н. и др. Преждевременные роды у женщин с сахарным диабетом // Журнал акушерства и женских болезней. 2020. Т. 69, № 1. C. 17–26. EDN: IURNDK doi: 10.17816/JOWD69117-26

[37] Abashova EI, Alekseenkova EN, Arzhanova ON, et al. Pregnancy’ and diabetes mellitus: a guide for doctors. Kogan IYu, editor. Moscow: GEOTAR-Media; 2023. (In Russ.) EDN: DZLETI doi: 10.33029/9704-7468-6-BSD-2023-1-272

[38] Абашова Е.И., Алексеенкова Е.Н., Аржанова О.Н., и др. Беременность и сахарный диабет: руководство для врачей / под ред. И.Ю. Когана. Москва: ГЭОТАР-Медиа, 2023. EDN: DZLETI doi: 10.33029/9704-7468-6-BSD-2023-1-272

[39] Evsyukova II. The impact of maternal obesity and diabetes on fetal brain development (mechanisms and prevention). Journal of Obstetrics and Women’s Diseases. 2020;69(3):33–38. EDN: WPVJWB doi: 10.17816/JOWD69333-38

[40] Евсюкова И.И. Влияние ожирения и сахарного диабета матери на развитие мозга ребенка (механизмы и профилактика) // Журнал акушерства и женских болезней. 2020. Т. 69, № 3. C. 33–38. EDN: WPVJWB doi: 10.17816/JOWD69333-38

[41] Robert MF, Neff RK, Hubbell JP, et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med. 1976;294(7):357–360. doi: 10.1056/NEJM197602122940702

[42] Robert M.F., Neff R.K., Hubbell J.P., et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn // N Engl J Med. 1976. Vol. 294, N. 7. P. 357–360. doi: 10.1056/NEJM197602122940702

[43] Neyman EG, Shit’kovskaya EP, Il’yenkova NA, et al. Features of the neonatal period in infants born to mothers with diabetes. Sibirskoye meditsinskoye obozreniye. 2014;(4):75–78. EDN: SLRTDV

[44] Нейман Е.Г., Шитьковская Е.П., Ильенкова Н.А., и др. Особенности неонатального периода у детей, рожденных от матерей с сахарным диабетом // Сибирское медицинское обозрение. 2014. № 4(88). С. 75–78. EDN: SLRTDV

[45] Prakash GT, Das AK, Habeebullah S, et al. Maternal and neonatal outcome in mothers with gestational diabetes mellitus. Indian J Endocrinol Metab. 2017;21(6):854–858. doi: 10.4103/ijem.IJEM_66_17

[46] Prakash G.T., Das A.K., Habeebullah S., et al. Maternal and neonatal outcome in mothers with gestational diabetes mellitus // Indian J Endocrinol Metab. 2017. Vol. 21, N. 6. P. 854–858. doi: 10.4103/ijem.IJEM_66_17

[47] Cnattingius S, Lindam A, Persson M. Risks of asphyxia-related neonatal complications in offspring of mothers with type 1 or type 2 diabetes: the impact of maternal overweight and obesity. Diabetologia. 2017;60(7):1244–1251. doi: 10.1007/s00125-017-4279-2

[48] Cnattingius S., Lindam A., Persson M. Risks of asphyxia-related neonatal complications in offspring of mothers with type 1 or type 2 diabetes: the impact of maternal overweight and obesity // Diabetologia. 2017. Vol. 60, N. 7. P. 244–1251. doi: 10.1007/s00125-017-4279-2

[49] Aksenov AN, Bocharova II, Bashakin NF, et al. Specific features of early postnatal adaptation and management of neonates born to mothers with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2015;15(4):75–80. EDN: VBEQXT doi: 10.17116/rosakush201515475-80

[50] Аксенов А.Н., Бочарова И.И., Башакин Н.Ф., и др. Особенности ранней постнатальной адаптации и ведения новорожденных, родившихся у матерей с гестационным сахарным диабетом // Российский вестник акушера-гинеколога. 2015. Т. 15, № 4. С. 75–80. EDN: VBEQXT doi: 10.17116/rosakush201515475-80

[51] Logutova LS, Petrukhin VA, Bocharova II, et al. Monitoring of newborn infants born to mothers with gestational diabetes mellitus. Russian Bulletin of Obstetrician-Gynecologist. 2013;13(2):89–94. EDN: PYRMGZ

[52] Логутова Л.С., Петрухин В.А., Бочарова И.И., и др. Мониторинг новорожденных, родившихся у матерей с ге-стационным сахарным диабетом // Российский вестник акушера-гинеколога. 2013. Т. 13, № 2. С. 89–94. EDN: PYRMGZ

[53] Watson D, Rowan J, Neale L, Battin MR. Admissions to neonatal intensive care unit following pregnancies complicated by gestational or type 2 diabetes. Aust N Z J Obstet Gynaecol. 2003;43(6):429–432. doi: 10.1046/j.0004-8666.2003.00116.x

[54] Watson D., Rowan J., Neale L., et al. Admissions to neonatal intensive care unit following pregnancies complicated by gestational or type 2 diabetes // Aust N Z J Obstet Gynaecol. 2003. Vol. 43, N. 6. P. 429–432. doi: 10.1046/j.0004-8666.2003.00116.x

[55] Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998;179(2):476–480. doi: 10.1016/s0002-9378(98)70382-5

[56] Nesbitt T.S., Gilbert W.M., Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California // Am J Obstet Gynecol. 1998. Vol. 179, N. 2. P. 476–480. doi: 10.1016/s0002-9378(98)70382-5

[57] Ecker JL, Greenberg JA, Norwitz ER, et al. Birth weight as a predictor of brachial plexus injury. Obstet Gynecol. 1997;89(5(Pt.1):643–647. doi: 10.1016/s0029-7844(97)00007-0

[58] Ecker J.L., Greenberg J.A., Norwitz E.R., et al. Birth weight as a predictor of brachial plexus injury // Obstet Gynecol. 1997. Vol. 89, N. 5, Pt. 1. P. 643–647. doi: 10.1016/s0029-7844(97)00007-0

[59] Kapustin RV, Kopteeva EV, Alekseenkova EN, et al. Risk factors for shoulder dystocia during labor in women with diabetes mellitus. Obstetrics and Gynecology. 2022;(9):54–63. EDN: UEQFGQ doi: 10.18565/aig.2022.9.54-63

[60] Капустин Р.В., Коптеева Е.В., Алексеенкова Е.Н., и др. Анализ факторов риска дистоции плечиков плода в родах у женщин с сахарным диабетом // Акушерство и гинекология. 2022. № 9. С. 54–63. EDN: UEQFGQ doi: 10.18565/aig.2022.9.54-63

[61] Flores-le Roux JA, Sagarra E, Benaiges D, et al. A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus. Diabetes Research and Clinical Practice. 2012;97(2):217–222. doi: 10.1016/j.diabres.2012.03.011

[62] Flores-le Roux J.A., Sagarra E., Benaiges D., et al. A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus // Diabetes research and clinical practice. 2012. Vol. 97, N. 2. P. 217–222. doi: 10.1016/j.diabres.2012.03.011

[63] Maayan-Metzger A, Lubin D, Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology. 2009;96(2):80–85. doi: 10.1159/000203337.

[64] Maayan-Metzger A., Lubin D., Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers // Neonatology. 2009. Vol. 96, N. 2. P. 80–85. doi: 10.1159/000203337.

[65] Lupo PJ, Canfield MA, Chapa C, et al. Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study. Am J Epidemiol. 2012;176(12):1101–1109. doi: 10.1093/aje/kws190

[66] Lupo P.J., Xanbfied M.A., Chapa C., et al. Diabetes and obesity related genes and the risk of neural tube defects in the national birth defects prevention study // Am J Epidemiol. 2012. Vol. 176, N. 12. P. 1101–1109. doi: 10.1093/aje/kws190

RIGHTS & PERMISSIONS

Eсо-Vector